Ozempic maker Novo Nordisk to cut 9,000 jobs amid increased competition
Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly Business live – latest newsThe Danish maker of the weight-loss and diabetes drugs Wegovy and Ozempic is to cut 9,000 jobs as it issued a profit warning amid fierce competition from its US rival Eli Lilly.Novo Nordisk’s decision to cut 11% of its global workforce of 78,400 take place as sales of Wegovy have slowed sharply as it has lost ground to Eli Lilly’s Mounjaro jabs, as well as cheaper versions made by generic drugmakers, and the pharmaceutical sector faces the threat of targeted US tariffs. Continue reading...
admin
0
15
Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly
The Danish maker of the weight-loss and diabetes drugs Wegovy and Ozempic is to cut 9,000 jobs as it issued a profit warning amid fierce competition from its US rival Eli Lilly.
Novo Nordisk’s decision to cut 11% of its global workforce of 78,400 take place as sales of Wegovy have slowed sharply as it has lost ground to Eli Lilly’s Mounjaro jabs, as well as cheaper versions made by generic drugmakers, and the pharmaceutical sector faces the threat of targeted US tariffs.
Continue reading...
